Related Experiment Videos
The impact of diagnostic immunohistochemistry on patient outcomes
M R Wick1, J H Ritter, P E Swanson
1Robert E. Fechner Laboratory of Surgical Pathology, University of Virginia Medical Center, Charlottesville, USA.
Insights
Diagnostic immunohistology (DIHC) offers valuable clinical applications, including identifying infections and differentiating tumors. However, its impact on patient outcomes needs further formal analysis, especially for prognostication.
Area of Science:
- Medical diagnostics
- Pathology
- Immunohistochemistry
Background:
- Diagnostic immunohistology (DIHC) has been clinically utilized for over 20 years.
- Medicolegal issues have historically limited formal outcomes analyses of DIHC.
- DIHC has potential applications in clinical decision-making and patient management.
Purpose of the Study:
- To evaluate the clinical applications of DIHC.
- To assess the impact of DIHC on patient outcomes.
- To identify areas where formal outcomes analysis is needed for DIHC.
Main Methods:
- Review of existing literature on DIHC applications.
- Analysis of potential impacts on patient outcomes based on DIHC's roles.
- Discussion of medicolegal factors influencing outcomes research.
Main Results:
- DIHC accurately identifies infectious organisms and distinguishes between undifferentiated tumors, potentially impacting outcomes.
- DIHC's roles in separating benign/malignant neoplasms and prognostication have questionable quantifiable outcome value.
- Formal outcomes analysis for DIHC is currently lacking.
Conclusions:
- DIHC has established value in specific diagnostic contexts.
- Further outcomes research is crucial to define DIHC's precise role in patient management and treatment response.
- Standardized outcomes analysis is needed to guide future DIHC practice patterns.
Abstract:
Diagnostic immunohistology (DIHC) is a discipline that has been used clinically for at least two decades, but, because of medicolegal encumbrances, it has not been a part of many formal outcomes analyses during that time. Potential applications of this technology with a direct bearing on response to treatment include the accurate identification of infectious organisms, distinction between morphologically-similar undifferentiated tumors, separation of benign and malignant neoplasms, and prognostication of malignancies. The first two of those four roles may indeed have a quantifiable impact on case outcomes, but the last two applications have only questionable value in this specific context. This is an area of medicine in which formal outcomes analysis is greatly needed to help determine future practice patterns.